Altered phenotype of NK cells from obese rats can be normalized by transfer into lean animals

Obesity

Volumn 17, Issue 10, 2009, Pages 1848-1855

  Lautenbach, Anne ^a   Wrann, Christiane D ^a   Jacobs, Roland ^a   Müller, Guenter ^b   Brabant, Georg ^c   Nave, Heike ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2; LEPTIN RECEPTOR; STAT3 PROTEIN; STAT3 PROTEIN, RAT;

ADOPTIVE TRANSFER; ANIMAL; ARTICLE; BLOOD; FISCHER 344 RAT; FLOW CYTOMETRY; GERMFREE ANIMAL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LIVER; LUNG; MALE; NATURAL KILLER CELL; OBESITY; PATHOLOGY; PHENOTYPE; RANDOMIZATION; RAT; SIGNAL TRANSDUCTION; SPLEEN;

ADOPTIVE TRANSFER; ANIMALS; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; JANUS KINASE 2; KILLER CELLS, NATURAL; LIVER; LUNG; MALE; OBESITY; PHENOTYPE; RANDOM ALLOCATION; RATS; RATS, INBRED F344; RECEPTORS, LEPTIN; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; STAT3 TRANSCRIPTION FACTOR;

ANIMALIA; RATTUS;

EID: 70349519063     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.140     Document Type: Article

References (40)

1. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev 2007;29:1-5.
2. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-591.
3. Dixit VD. Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span. J Leukoc Biol 2008;84:882-892.
4. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000;62:413-437.
5. Zhang Y, Proenca R, Maffei M et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
6. Brabant G, Nave H, Mayr B et al. Secretion of free and protein-bound leptin from subcutaneous adipose tissue of lean and obese women. J Clin Endocrinol Metab 2002;87:3966-3970.
7. Tartaglia LA, Dembski M, Weng X et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263-1271.
8. Badman MK, Flier JS. The adipocyte as an active participant in energy balance and metabolism. Gastroenterology 2007;132:2103-2115.
9. La Cava A, Matarese G. The weight of leptin in immunity. Nat Rev Immunol 2004;4:371-379.
10. Brabant G, Müller G, Horn R et al. Hepatic leptin signaling in obesity. FASEB J 2005;19:1048-1050.
11. Sinha MK, Opentanova I, Ohannesian JP et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996;98:1277-1282.
12. Tilg H, Hotamisligil GS. Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 2006;131:934-945.
13. Tilg H, Kaser A, Moschen AR. How to modulate inflammatory cytokines in liver diseases. Liver Int 2006;26:1029-1039.
14. Mori A, Sakurai H, Choo MK et al. Severe pulmonary metastasis in obese and diabetic mice. Int J Cancer 2006;119:2760-2767.
15. Nave H, Mueller G, Siegmund B et al. Resistance of Janus kinase-2 dependent leptin signaling in natural killer (NK) cells: a novel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology 2008;149:3370-3378.
16. Tian Z, Sun R, Wei H, Gao B. Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochem Biophys Res Commun 2002;298:297-302.
17. Zhao Y, Sun R, You L, Gao C, Tian Z. Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem Biophys Res Commun 2003;300:247-252.
18. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008;9:503-510.
19. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008;9:495-502.
20. Ferrante AW Jr. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med 2007;262:408-414.
21. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-867.
22. Spiegelman BM, Hotamisligil GS. Through thick and thin: wasting, obesity, and TNF alpha. Cell 1993;73:625-627.
23. Grégoire C, Cognet C, Chasson L et al. Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation. Eur J Immunol 2008;38:2076-2084.
24. Falagas ME, Michalopoulos A. Polymyxins: old antibiotics are back. Lancet 2006;367:633-634.
25. Colucci F, Caligiuri MA, Di Santo J P. What does it take to make a natural killer? Nat Rev Immunol 2003;3:413-425.
26. Wiltrout RH. Regulation and antimetastatic functions of liver-associated natural killer cells. Immunol Rev 2000;174:63-76.
27. Ranson T, Vosshenrich CA, Corcuff E et al. IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 2003;101:4887-4893. (Pubitemid 36857750)
28. Elinav E, Pappo O, Sklair-Levy M et al. Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping. J Pathol 2006;209:121-128.
29. Bulló M, García-Lorda P, Megias I, Salas-Salvadó J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 2003;11:525-531.
30. Festa A, D'Agostino R Jr, Williams K et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001;25:1407-1415.
31. Muoio DM, Newgard CB. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 2008;9:193-205.
32. Vosshenrich CA, Ranson T, Samson SI et al. Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol 2005;174:1213-1221.
33. Gommerman JL, Browning JL. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat Rev Immunol 2003;3:642-655.
34. Hagemann T, Lawrence T, McNeish I et al. "Re-educating" tumor-associated macrophages by targeting NF-kappaB. J Exp Med 2008;205:1261-1268.
35. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007;447:1116-1120.
36. Lehrke M, Lazar MA. The many faces of PPARgamma. Cell 2005; 123:993-999.
37. Rutter GA, Da Silva Xavier G, Leclerc I. Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J 2003;375:1-16.
38. Lamas O, Marti A, Martínez JA. Obesity and immunocompetence. Eur J Clin Nutr 2002;56(Suppl 3):S42-S45.
39. Cottam DR, Schaefer PA, Shaftan GW, Angus LD. Dysfunctional immune-privilege in morbid obesity: implications and effect of gastric bypass surgery. Obes Surg 2003;13:49-57.
40. Lo JC, Wang Y, Tumanov AV et al. Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science 2007;316:285-288.